Gundry MD® Bio Complete 3™, developed by heart surgeon and gut health expert Dr. Steven Gundry, has earned more than 2,400 ...

A Multi-Enzyme Blend Was Tested and Validated in a Newly Adapted In Vitro Digestion Simulation Protocol TROY, Va., May 3, 2022 /PRNewswire/ -- A clinical trial designed by BIO-CAT, Inc – a biotech ...

Palisade Bio is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. The Company believes that by using a targeted approach with its ...

Palisade Bio's PALI-2108 will be presented at Digestive Disease Week 2025, highlighting its potential in ulcerative colitis treatment. Palisade Bio's lead program PALI-2108 has been recognized, being ...

The gastrointestinal system comprises a plethora of different cell types that develop, interact, specialize and function in a complex, tightly regulated process and, in many cases, show remarkable ...

Peptide mapping is an essential step in characterizing, identifying, and monitoring a wide range of properties of target proteins in biotherapeutic studies. Peptide mapping for biotherapeutic proteins ...